Agios Pharmaceuticals | AGIO - Stock

Agios Pharmaceuticals reported $8.49M in Stock for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Stock Change
Agios Pharmaceuticals AGIO:US USD 8.49M 3.32M
Alnylam Pharmaceuticals ALNY:US USD 128.96M 13.47M
Amgen AMGN:US USD 4.93B 173M
Astellas Pharma 4503:JP JPY 163.22B 5.42B
Biogen BIIB:US USD 1.34B 30.6M
Biomarin Pharmaceutical BMRN:US USD 894.08M 54.62M
Daiichi Sankyo 4568:JP JPY 266.68B 4.56B
Exelixis EXEL:US USD 33.3M 6.59M
Gilead Sciences GILD:US USD 2.82B 218M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
IONIS PHARMACEUT IONS:US USD 22.03M 1.39M
JAZZ PHA JAZZ:US USD 714.06M 14.01M
Moderna Inc MRNA:US USD 949M 1.13B
Nektar Therapeutics NKTR:US USD 19.2M 145K
Novartis NOVN:VX USD 7.18B 396M
Puma Biotechnology PBYI:US USD 4.53M 926K
Regeneron Pharmaceuticals REGN:US USD 2.4B 10.3M
Roche Holding ROG:VX 8.6B 313M
Sarepta Therapeutics SRPT:US USD 203.97M 17.22M
Seattle Genetics SGEN:US USD 427.21M 62.24M
Vertex Pharmaceuticals VRTX:US USD 460.6M 72.4M
YTE INCY:US USD 120.96M 75.09M